- Home
- ABSI vs OLMA Comparison
ABSI vs OLMA Comparison
Compare ABSI & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABSI | OLMA |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 997.8M | 949.3M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ABSI | OLMA |
|---|---|---|
| Price | $8.65 | $10.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $6.96 | ★ $44.89 |
| AVG Volume (30 Days) | ★ 2.7M | 923.5K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 10.64 | ★ 15.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,534,000.00 | N/A |
| Revenue This Year | $215.96 | N/A |
| Revenue Next Year | $319.10 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.24 | $6.65 |
| 52 Week High | $12.06 | $36.26 |
Technical Indicators
Market Signals| Indicator | ABSI | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 47.86 | 43.34 |
| Support Level | $8.55 | $9.89 |
| Resistance Level | $10.03 | $11.36 |
| Average True Range (ATR) | 0.55 | 0.46 |
| MACD | -0.07 | 0.03 |
| Stochastic Oscillator | 23.35 | 28.08 |
Price Performance
Historical ComparisonAbout ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.